Automated Insulin Delivery Works Well for Older Adults with Type 1 Diabetes

A comprehensive review of studies shows that automated insulin delivery systems help older adults achieve better blood sugar control and lower stress—without increasing low blood sugar episodes.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

living with t1dmental healthtechnologysupport

Key takeaways

Automated insulin delivery systems help older adults reach their target blood sugar range about 78% of the time
Users saw their HbA1c (average blood sugar over three months) drop by about 0.36% on average
Low blood sugar events did not increase with automated systems, addressing a common concern
Age alone should not prevent someone from using these technologies

What the Research Shows

Researchers reviewed nine studies involving 8,765 older adults (age 60 and above) with type 1 diabetes who used automated insulin delivery systems. These systems automatically adjust insulin doses based on continuous glucose readings, reducing the need for manual calculations and decisions.

The results were encouraging. On average, users spent about 78% of their time in their target blood sugar range—a key marker of good diabetes management. Their HbA1c improved by 0.36%, meaning better overall blood sugar control over time. Importantly, users experienced only 1.35% of time below 70 mg/dL, showing that automated systems did not cause more low blood sugar episodes.

Better Control, Less Stress

Beyond the numbers, the research found that older adults using automated insulin delivery reported lower diabetes distress—the emotional and mental burden that comes with managing type 1 diabetes daily. This finding matters because quality of life is as important as blood sugar numbers when living with diabetes long-term.

Age Is Not a Barrier

Older adults with type 1 diabetes are a diverse group. Some have sharp minds and steady hands; others face memory changes, arthritis, or other health conditions. Some have family caregivers; others live independently. These differences matter, which is why the researchers emphasize that decisions about automated insulin delivery should be made individually, not based on age alone.

The evidence suggests that older adults—when properly supported and trained—can benefit from these technologies just as younger users do. A healthcare team can assess whether an automated system is right for a specific person, considering their cognition, physical abilities, lifestyle, and goals.

What This Means

If you or an older loved one with type 1 diabetes has wondered whether automated insulin delivery is feasible, this research offers reassurance. The systems appear safe and effective in this age group, with results consistent with what has been seen in younger adults. The key is working with your healthcare team to determine whether this technology fits your individual situation, needs, and preferences.

Evidence label

Source: Diabetes research and clinical practice. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.